EAM
UTHR icon

Erste Asset Management’s United Therapeutics UTHR Stock Holding History

Erste Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7M Buy
28,831
+2,167
+8% +$1.22M 0.12% 164
2026
Q1 		$15.7M Sell
26,664
-16,347
-38% -$8.14M 0.15% 149
2025
Q4 		$21.5M Buy
43,011
+5,223
+14% +$2.43M 0.18% 120
2025
Q3 		$16.1M Sell
37,788
-5,174
-12% -$1.74M 0.16% 147
2025
Q2 		$12.2M Buy
42,962
+3,667
+9% +$1.1M 0.1% 177
2025
Q1 		$12.1M Sell
39,295
-7,841
-17% -$2.69M 0.16% 138
2024
Q4 		$17M Buy
47,136
+1,870
+4% +$687K 0.21% 115
2024
Q3 		$16.2M Sell
45,266
-1,784
-4% -$603K 0.19% 128
2024
Q2 		$14.9M Buy
47,050
+597
+1% +$158K 0.2% 123
2024
Q1 		$11.1M Buy
46,453
+3,664
+9% +$827K 0.15% 145
2023
Q4 		$9.36M Buy
42,789
+3,835
+10% +$884K 0.14% 152
2023
Q3 		$8.83M Buy
38,954
+1,166
+3% +$269K 0.15% 148
2023
Q2 		$8.3M Buy
37,788
+2,067
+6% +$458K 0.15% 158
2023
Q1 		$7.86M Buy
35,721
+6,280
+21% +$1.55M 0.15% 157
2022
Q4 		$8.14M Buy
29,441
+14,666
+99% +$3.7M 0.17% 150
2022
Q3 		$3.07M Buy
14,775
+252
+2% +$56.3K 0.07% 243
2022
Q2 		$3.46M Buy
14,523
+563
+4% +$114K 0.08% 243
2022
Q1 		$2.45M Buy
13,960
+1,649
+13% +$314K 0.05% 275
2021
Q4 		$2.65M Buy
12,311
+1,811
+17% +$356K 0.05% 268
2021
Q3 		$1.95M Hold
10,500
– – 0.04% 274
2021
Q2 		$1.86M Buy
+10,500
New +$2M 0.04% 291

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Erste Asset Management's UTHR Position: Q2 2026 in Review

Erste Asset Management increased its United Therapeutics (UTHR) stake by 8.1% in Q2 2026, buying an estimated $1.22M and bringing the position to 28,831 shares worth $15.7M. The position accounts for 0.12% of the portfolio, ranked #164.

Erste Asset Management first reported a position in UTHR in Q2 2021 and has held it in 21 quarters since. The position peaked at $21.5M in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Erste Asset Management held 28,831 shares of United Therapeutics worth $15.7M as of Q2 2026.
  • Erste Asset Management bought 2,167 United Therapeutics shares in Q2 2026, an estimated $1.22M.
  • United Therapeutics made up 0.12% of Erste Asset Management's portfolio in Q2 2026, its #164 holding.
  • Erste Asset Management first reported a position in United Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Erste Asset Management's United Therapeutics position peaked at $21.5M in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.